Oxford MEStar Ltd (“MEStar”), an Oxford University spin-out, has acquired selected intellectual property, trademarks and assets from Mode Diagnostics Ltd (“Mode”) for an undisclosed sum.
Professor Zhanfeng Cui, the founder of MEStar, commented: “We are excited about the long term commercial potential of using this technology. We believe the IP developed by Mode, a proprietary electrochemical detection technology, is an important component that we can use to develop handheld test devices manufactured at low cost and in high volumes. As Mode demonstrated what could be done with its bowel health test, we hope in future to use the same technology to develop products for other cancers and infectious diseases. We will continue to work in partnership with the University of Glasgow and maintain a corporate presence in Scotland”.
ABOUT MESTAR
Oxford MEStar Limited is a spin-out company from the Institute of Biomedical Engineering of Oxford University specializing in translational and regenerative medicine and healthcare. The company is focused on a) developing novel technologies; b) offering bioengineering solutions to clients; and c) technology transfer between the UK and China.
For more information, please contact Dr Zoe Li on 01865 784436 or visit www.oxford-mestar.com
ABOUT MODE DIAGNOSTICS
Mode Diagnostics Limited, a University of Glasgow spin-out company, backed by amongst others, IP Group plc and the Scottish Investment Bank, the investment arm of Scottish Enterprise, developed and commercialised a consumer health test for bowel health.
